| 101 |
32984343 | Bruton's Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells. | 2020 |
1 |
| 102 |
33052979 | Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1. | 2020 |
1 |
| 103 |
33163405 | Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter. | 2020 |
1 |
| 104 |
33305727 | Reduced cytotoxicity in doxorubicin-exposed HepG2 cells pretreated with menthol due to upregulation of P-glycoprotein. | 2020 Oct 1 |
6 |
| 105 |
33351694 | circ_0002060 Enhances Doxorubicin Resistance in Osteosarcoma by Regulating the miR-198/ABCB1 Axis. | 2020 Dec 22 |
3 |
| 106 |
33365267 | Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells. | 2020 |
1 |
| 107 |
30032164 | miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1. | 2019 Mar |
2 |
| 108 |
30039475 | Therapeutic Potential of DNAzyme Loaded on Chitosan/Cyclodextrin Nanoparticle to Recovery of Chemosensitivity in the MCF-7 Cell Line. | 2019 Mar |
2 |
| 109 |
30066239 | Selective inhibition of P-gp transporter by goniothalamin derivatives sensitizes resistant cancer cells to chemotherapy. | 2019 Jan |
1 |
| 110 |
30171603 | Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein. | 2019 Apr |
1 |
| 111 |
30318192 | Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug. | 2019 Jan 1 |
4 |
| 112 |
30342318 | Ferulic acid reverses P-glycoprotein-mediated multidrug resistance via inhibition of PI3K/Akt/NF-κB signaling pathway. | 2019 Jan |
1 |
| 113 |
30430199 | Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma. | 2019 Feb |
2 |
| 114 |
30465789 | Histone deacetylase 2 regulates the doxorubicin (Dox) resistance of hepatocarcinoma cells and transcription of ABCB1. | 2019 Jan 1 |
3 |
| 115 |
30471372 | Effect of chitosan based glycolipid-like nanocarrier in prevention of developing acquired drug resistance in tri-cycle treatment of breast cancer. | 2019 Jan 30 |
7 |
| 116 |
30483812 | Levistolide A synergistically enhances doxorubicin‑induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway. | 2019 Feb |
4 |
| 117 |
30538042 | Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism. | 2019 Jan 15 |
1 |
| 118 |
30572191 | Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin. | 2019 Feb 20 |
2 |
| 119 |
30609135 | Resveratrol potentially increased the tumoricidal effect of doxorubicin on SKOV3 cancer stem cells in vitro. | 2019 Jan 4 |
2 |
| 120 |
30623608 | Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression. | 2019 Mar |
3 |
| 121 |
30650062 | MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer. | 2019 Mar |
3 |
| 122 |
30668405 | Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells. | 2019 Feb |
1 |
| 123 |
30676767 | MIX2: A Novel Natural Multi-Component Modulator of Multidrug-Resistance and Hallmarks of Cancer Cells. | 2019 |
1 |
| 124 |
30742940 | Oncogenic PITX2 facilitates tumor cell drug resistance by inverse regulation of hOCT3/SLC22A3 and ABC drug transporters in colon and kidney cancers. | 2019 May 1 |
1 |
| 125 |
30745853 | Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A. | 2019 |
1 |
| 126 |
30760665 | CCL20 Promotes Ovarian Cancer Chemotherapy Resistance by Regulating ABCB1 Expression. | 2019 |
3 |
| 127 |
30904920 | Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein. | 2019 Mar 24 |
1 |
| 128 |
30924055 | The Effects of Iodinated Radiographic Contrast Media on Multidrug-resistant K562/Dox Cells: Mitochondria Impairment and P-glycoprotein Inhibition. | 2019 Jun |
1 |
| 129 |
30926883 | Multifunctional Gold Nanoparticles Overcome MicroRNA Regulatory Network Mediated-Multidrug Resistant Leukemia. | 2019 Mar 29 |
2 |
| 130 |
30937974 | Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway. | 2019 Jun |
1 |
| 131 |
30940690 | Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells. | 2019 Sep |
1 |
| 132 |
30959046 | Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. | 2019 Jun 5 |
6 |
| 133 |
30964927 | Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression. | 2019 |
1 |
| 134 |
30967374 | Intercellular transfer of P-glycoprotein mediates the formation of stable multi-drug resistance in human bladder cancer BIU-87 cells. | 2019 May 1 |
3 |
| 135 |
30977678 | ABCB1 (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide. | 2019 May |
8 |
| 136 |
30982500 | C-terminal truncated HBx reduces doxorubicin cytotoxicity via ABCB1 upregulation in Huh-7 hepatocellular carcinoma cells. | 2019 May |
8 |
| 137 |
30997984 | pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells. | 2019 May 8 |
2 |
| 138 |
30998372 | Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer. | 2019 Jun 3 |
5 |
| 139 |
31047947 | Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts. | 2019 Aug 1 |
9 |
| 140 |
31048454 | Coexpression of ABCB1 and ABCG2 in a Cell Line Model Reveals Both Independent and Additive Transporter Function. | 2019 Jul |
1 |
| 141 |
31087712 | Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin-resistance leukemia cancer cells to treatment. | 2019 Sep |
1 |
| 142 |
31103263 | Intracellular Doppler Spectroscopy detects altered drug response in SKOV3 tumor spheroids with silenced or inhibited P-glycoprotein. | 2019 Jul 5 |
1 |
| 143 |
31180580 | LncRNA FENDRR attenuates adriamycin resistance via suppressing MDR1 expression through sponging HuR and miR-184 in chronic myelogenous leukaemia cells. | 2019 Aug |
1 |
| 144 |
31190812 | Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect. | 2019 |
4 |
| 145 |
31202598 | Designed P-glycoprotein inhibitors with triazol-tetrahydroisoquinoline-core increase doxorubicin-induced mortality in multidrug resistant K562/A02 cells. | 2019 Aug 1 |
1 |
| 146 |
31207578 | Teratogenic jervine increases the activity of doxorubicin in MCF-7/ADR cells by inhibiting ABCB1. | 2019 Sep |
2 |
| 147 |
31209929 | Estimation of ABCB1 concentration in plasma membrane. | 2019 Oct |
1 |
| 148 |
31235998 | MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells. | 2019 Jun 14 |
2 |
| 149 |
31249297 | ABCB1 protects bat cells from DNA damage induced by genotoxic compounds. | 2019 Jun 27 |
1 |
| 150 |
31258739 | Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression. | 2019 |
6 |